| Literature DB >> 31483560 |
Federica Tonolo1, Michèle Salmain2, Valeria Scalcon1, Siden Top2, Pascal Pigeon2,3, Alessandra Folda1, Benoit Caron4, Michael J McGlinchey5, Robert-Alain Toillon6, Alberto Bindoli7, Gérard Jaouen2,3, Anne Vessières2, Maria Pia Rigobello1.
Abstract
The ferrocenyl diphenol complexes 1,1-bis(4'-hydroxyphenyl)-2-ferrocenyl-but-1-ene (1) and 1,2-bis(4'-hydroxyphenyl)-1-ferrocenyl-but-1-ene [(Z)-2], which differ by the relative position of the two phenolic substituents, display dramatically different antiproliferative activities on cancer cells (1 is far more cytotoxic than 2). In this study, our goal was to discover the origin of this difference by comparing their reactivity and biological behaviour. In terms of common behaviour, we found that 1 and 2 are both efficient inhibitors of thioredoxin reductase (TrxR) in vitro after oxidation by a horseradish peroxidase/H2 O2 system. However, as 1 is only a moderate inhibitor of TrxR in MDA-MB-231 cells, TrxR is probably not the major target responsible for the cytotoxicity of 1. In terms of differences, we noted that 1 induced a significant redox imbalance characterised by lipid peroxidation and thiol oxidation, and a moderate decrease of the mitochondrial membrane potential in breast cancer cells, whereas 2 has almost no effect. These results underline the importance of the trans configuration in the ferrocenyl-double bond-phenol motif, which is present in 1 but is cis in (Z)-2.Entities:
Keywords: bioorganometallic chemistry; cancer; iron; lipid peroxidation; thioredoxin reductase
Mesh:
Substances:
Year: 2019 PMID: 31483560 DOI: 10.1002/cmdc.201900430
Source DB: PubMed Journal: ChemMedChem ISSN: 1860-7179 Impact factor: 3.466